Keytruda ® 100 mg/4 ml 1 vial

Keytruda ® 100 mg/4 ml 1 vial

Product contains 100 mg of PEMBROLIZUMAB.

Manufactured by Merck Sharp & Dohme. (Oncology)

Therapeutic properties:

Keytruda is used in the treatment of a form of skin cancer also known as melanoma.

Keytruda helps your immune system for fighting cancer.

Side Effects:

Gastrointestinal problems for example diarrhea, constipation.

Vomiting as a result of nausea.

Allergic reactions for example itching, skin rash.

Joint pain.

Tiredness.

Decrease in thrombocyte count.

Loss of appetite, as a result of that; weight loss.

Desert mouth.

Headache.

Asthenia for example weakness, dizziness.

Cough, shortness of breath.

Hair loss because of hair thinning.

Anemia.

Dosage:

Please especially consult your doctor for the best dosage.

Product should be administered by specifically intravenous infusion over 30 minutes.

Tips:

Take tablets carefully while you had liver or renal transplantation before.

Product does not recommend for patients under the age of 18.

Do not stop taking product before consulting your doctor.

Dose adjustment does not require for patients who have liver or renal insufficiency.

You should use an effective contraception method up to 4 months after your Keytruda treatment.

Product contains sucrose.

This summary does NOT contain all possible information about this product.

You can buy Keytruda ® 100 mg/4 ml 1 vial here above and you can also check our other Oncology Products here.